Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON30757Phase 2Active, not recruiting
Phase 2, randomised, double-blind trial in rheumatoid arthritis (RA) comparing ACZ885 + methotrexate with placebo + methotrexate (2 arms). Primary endpoint: ACR50 response at 26 weeks. Started Jul 2007; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON30757.